Leadership Change Within Palliative Care Program
In that time, the program has gained national recognition, with Dr. Cleary serving as President of the American Academy of Hospice and Palliative Medicine in 2004 and Chair of the US Hospice and Palliative Care Coalition.
Under his leadership the UW Carbone Cancer Center has demonstrated excellence in many cost and quality outcome measures for NCI designated Cancer Centers as measured by the Dartmouth Atlas.
Dr. Cleary will increase his involvement and leadership of the Pain and Policy Studies Group and the WHO Collaborating Center for Pain Policy and Palliative Care with funding support from Livestrong and the Open Society Foundation.
It is our pleasure to announce that the position of Clinical Director will be assumed by Toby Campbell, MD, MSCI. Dr. Campbell was appointed to the Department of Medicine in 2007 after completion of fellowship training in both Oncology and Palliative Medicine at Northwestern University. Dr. Campbell is a graduate of the University of Virginia where he received his undergraduate and MD degrees. He completed internal medicine residency at the University of Wisconsin.
Dr. Campbell has both clinical and research interests in symptom management and communication. He created a communication workshop, called WiTALK ("we talk") which is expanding to involve a number of residency programs. He also has several grant-funded research projects in the treatment of painful chemotherapy-induced peripheral neuropathy.
Dr. Campbell has received numerous clinical and research awards during his career including compassionate care awards at UVA, UW, and Northwestern. He received young investigator awards from both the American Society of Clinical Oncology (ASCO) and the International Association for the Study of Lung Cancer (IASLC). He has received grant funding for projects in chemotherapy induced peripheral neuropathy from ICTR, The American Cancer Society, and the UW Carbone Cancer Center. Dr. Campbell is a participant in the UW Medical Foundation's Physician Leadership Development Program under the direction of Roger Formisano.
Dr. Campbell brings his energy, enthusiasm, intelligence, and commitment to the advancement of high quality care for patients nearing the end of life. He is an ideal choice to replace Dr. Cleary and lead the program into a phase of expansion that further increases the impact of palliative care for seriously ill patients.
Date Published: 06/30/2011